New options to treat patients with Age-Related Macular Degeneration (ARMD or AMD) and Diabetic Retinopathy (DR), not to mention a host of other posterior disorders, are here. And as new retina medications and indications come to market, physicians are excited to adopt the new injectable drugs to facilitate a better quality of life for their patients by saving or stabilizing their vision.